FDA grants Priority Review status for TLX250-CDx for kidney cancer PET/CT scans
The Food and Drug Administration (FDA) in America has accepted [...]
89Zr-DFO-girentuximab for PET/CT imaging of kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
New PET imaging agent for kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
Artificial intelligence has potential to improve urology services
There has been growing interest around the use artificial intelligence [...]
AI tools to speed up cancer diagnosis
In June, the government provided NHS England with £21m to [...]
Early cancer detection test using ctDNA
A new multi-cancer early detection blood test could speed up [...]
Cancer Research UK: Workshop on diagnostic tests for cancer
Sharon Deveson Kell was invited by Cancer52 to represent the [...]
Results from a phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. [...]
Community diagnostic centres to tackle the COVID backlogs
Community diagnostic centres have been set up across England to [...]
NHS England to trial new blood test for over 50 types of cancer
NHS England is about to start a large-scale trial of [...]
